Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT02743221

Completed

A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy (TASCO1)

Metastatic Colorectal Cancer
NCT00998166

Terminated

A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy

Non-Small Cell Lung Cancer
NCT00020046

Completed

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer
NCT03766425

Completed

Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.

Eye Diseases | Glaucoma Surgery | Optic Nerve Damage
NCT05340205

Completed

Blood Loss During Cesarean Delivery in Placenta Previa Patients

Placenta Previa
NCT01180959

Completed

Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy

Liver Cancer
NCT04778917

Completed

Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer

Pneumonia
NCT01847573

Terminated

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy
NCT03367143

Unknown

Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL

Diffuse Large B-Cell Lymphoma Refractory
NCT00974233

Completed

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma
NCT03912402

Unknown

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

Cervical Cancer | Cervical Cancer Recurrent | Cervical Cancer Metastatic
NCT01303965

Terminated

Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)

Multiple Myeloma
NCT03751163

Completed

Oral Tranexamic Acid and Topical Hydroquinone in the Treatment of Melasma

Melasma
NCT03585179

Unknown

Oral and Topical Tranexamic Acid for the Treatment of Melasma (TRANEXAMICO)

Melanosis | Melasma | Chloasma
NCT02355028

Completed

LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration

Exudative Age-Related Macular Degeneration
NCT00006358

Completed

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Brain and Central Nervous System Tumors
NCT02966002

Terminated

Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients

Fontan Procedure
NCT00365144

Completed

Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine

Pancreatic Cancer
NCT03191981

Withdrawn

Pembrolizumab Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple Myeloma (MUKfourteen)

Myeloma Multiple
NCT03038607

Completed

Aspirin in Asymmetrically Intrauterine Growth

Intrauterine Growth Restriction Asymmetrical
NCT00798603

Completed

Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer
NCT01894555

Completed

Pharmacogenomics of Antiplatelet Response - II (PARes-II) (PARes-II)

Atherothrombosis
NCT01201265

Completed

A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer

Breast Cancer
NCT00942617

Withdrawn

Measurement of Platelet Dense Granule Release in Healthy Volunteers

Platelet Aggregation
NCT00276575

Completed

Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
NCT02283489

Unknown

Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors

Head and Neck Neoplasms
NCT00098865

Completed

Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma

Neuroblastoma | Central Nervous System Tumor, Pediatric
NCT00611728

Completed

Ph I SU011248 + Irinotecan in Treatment of Pts w MG

Glioblastoma
NCT00626561

Terminated

Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix

Cervical Cancer | Uterine Cancer
NCT02084342

Unknown

Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery

Idiopathic Scoliosis
NCT00033709

Unknown

Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma

Sarcoma
NCT00096018

Completed

Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia

Leukemia
NCT00670982

Completed

Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer

Breast Cancer
NCT00427310

Completed

Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery

Colorectal Cancer
NCT00849550

Completed

Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors. (COBRA)

Cancer | Unspecified Adult Solid Tumor, Protocol Specific
NCT00501345

Terminated

Aspirin in Patients With Myocardial Infarction and Thrombocytopenia

Myocardial Infarction | Thrombocytopenia
NCT00393094

Terminated

Bevacizumab and Irinotecan to Treat Brain Tumors

High-Grade Gliomas
NCT00334763

Terminated

Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer
NCT00979966

Completed

Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib

Non-clear Cell Renal Cell Cancer
NCT00251524

Completed

A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC

Non-Small Cell Lung Cancer
NCT00407563

Completed

Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer

Epithelial Ovarian Cancer | Primary Peritoneal Carcinoma
NCT00519688

Completed

UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT00293332

Terminated

Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Lung Cancer
NCT00000157

Terminated

Randomized Trial of Aspirin and Cataracts in U.S. Physicians

Cataract
NCT00856804

Unknown

Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance (TRITAL)

Hepatitis C
NCT07065435

Recruiting

RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study

HER2 + Breast Cancer
NCT06486181

Not yet recruiting

Second Line Endovascular Treatment in Acute DVT

Deep Venous Thrombosis
NCT05512702

Recruiting

Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary Thromboembolism

Pulmonary Embolism
NCT04140448

Recruiting

Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion (UWFA-RVO-ME)

Macular Edema | Retinal Vein Occlusion
NCT03854266

Recruiting

Low Dose Catheter Directed Thrombolysis for Acute Pulmonary Embolism (BETULA)

Pulmonary Embolism

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations